PATENT CLAIM ANALYSIS

Application Number: 15751782
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["544", "280000"]

Abstract:
Disclosed are a compound related to inhibiting the activity of an IRAK4 kinase, a pharmaceutical composition thereof, a use thereof in preparing drugs, a method in which same is used for inhibiting the activity of the IRAK4 kinase and a method in which same is used for treating and/or preventing IRAK4 kinase mediated diseases or conditions in mammals (especially humans). The compound has a structural formula I.

Claim (Index 3):
The compound according to  claim 1 , wherein:\n A is 5- to 6-membered heteroaryl, preferably furanyl, pyridinyl or pyrazolyl, optionally substituted with one or two C 1-6  alkyl groups, or a stereoisomer, tautomer, solvate or pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 88.0
- Lexical Diversity: 1.6087
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15022248', '15799315', '15314938', '14423078', '15257926']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8202961804852136
- 35 USC 102 Novelty (BERT): 0.5453459772482808
- Combined Prediction Score: 0.7928011601615202
- Mean Citation Score: 378.723926
- Max Citation Score: 398.73517
- Similarity Product: 316.6905649761557

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test